Bichen Pharmaceutical
Shanghai
About Bichen Pharmaceutical
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2022)
- Website: abmtx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bichen-pharmaceutical-78702 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.